TY - JOUR AU - Bracarda, Sergio AU - Mosillo, Claudia AU - Trippa, Fabio AU - Urbano, Federica AU - Maranzano, Ernesto AU - Caserta, Claudia PY - 2019 TI - No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases JF - Annals of Translational Medicine; Vol 7, No 22 (November 29, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - The prognosis of patients with metastatic renal cell carcinoma (mRCC) is evaluated by using the International Metastatic Renal Database Consortium risk score. Although the metastatic site is not counted in the prognostic classification, brain, liver, and bone metastases are normally considered as negative prognosticators (1). UR - https://atm.amegroups.org/article/view/32006